- Home
- ALIS vs BTMD Comparison
ALIS vs BTMD Comparison
Compare ALIS & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALIS | BTMD |
|---|---|---|
| Founded | 2024 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.9M | 72.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ALIS | BTMD |
|---|---|---|
| Price | $10.08 | $2.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.83 |
| AVG Volume (30 Days) | 5.1K | ★ 211.6K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ N/A | $33.92 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.87 | $1.27 |
| 52 Week High | $10.10 | $4.75 |
Technical Indicators
Market Signals| Indicator | ALIS | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 55.32 | 48.40 |
| Support Level | $10.05 | $1.97 |
| Resistance Level | N/A | $2.17 |
| Average True Range (ATR) | 0.01 | 0.14 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 62.62 | 37.58 |
Price Performance
Historical ComparisonAbout ALIS Calisa Acquisition Corp Ordinary shares
Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.